Tg Therapeutics reported $217.89M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Amgen AMGN:US USD 63.7B 4.41B
Ardelyx ARDX:US USD 144.67M 13.06M
Arrowhead Research ARWR:US USD 691.94M 59.84M
Bayer BAYN:GR EUR 131.01B 2.22B
Biogen BIIB:US USD 24.85B 227.2M
Corcept Therapeutics CORT:US USD 533.26M 36.89M
Curis CRIS:US USD 122.85M 5.98M
Dynavax Technologies DVAX:US USD 999.34M 23.66M
Gilead Sciences GILD:US USD 62.56B 313M
Infinity Pharmaceuticals INFI:US USD 51.59M 10.27M
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
Karyopharm Therapeutics KPTI:US USD 231.24M 25.24M
Novartis NOVN:VX USD 118.46B 4.45B
Novavax NVAX:US USD 2.27B 355.56M
Ptc Therapeutics PTCT:US USD 1.58B 227.66M
Puma Biotechnology PBYI:US USD 198.77M 5.12M
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Spectrum Pharmaceuticals SPPI:US USD 118.93M 39.5M
Tg Therapeutics TGTX:US USD 217.89M 33.78M
Verastem VSTM:US USD 111.1M 10.69M
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B
Ziopharm Oncology ZIOP:US USD 67.34M 6.59M